Evidera, a business unit of Pharmaceutical Product Development, LLC (PPD), has entered into an agreement to acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries. The acquisition will enable Evidera to offer its customers enhanced technology solutions, real-world data and access to health care providers.   Medimix solutions help clients gain insight into the real-worl...